Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program-Reference-Cited by-同舟云学术

Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program

Published:2022-07 Issue:7 Volume:20 Page:1576-1588
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Christopherson Pamela A.^ORCID,Haberichter Sandra L.,Flood Veronica H.,Perry Crystal L.,Sadler Brooke E.,Bellissimo Daniel B.,Di Paola Jorge^ORCID,Montgomery Robert R.,Abshire T,Weiler H,Lillicrap D,James P,O’Donnell J,Ng C,Bennett C,Sidonio R,Manco‐Johnson M,Journeycake J,Zia A,Lusher J,Rajpurkar M,Shapiro A,Lentz S,Gill J,Leissinger C,Ragni M,Tarantino M,Roberts J,Hord J,Strouse J,Ma A,Valentino L,Boggio L,Sharathkumar A,Gruppo R,Kerlin B,Kulkarni R,Green D,Hoots K,Brown D,Mahoney D,Mathias L,Bedros A,Diamond C,Neff A,DiMichele D,Giardina P,Cohen A,Paidas M,Werner E,Matsunaga A,Shafer F,Konkle B,Cuker A,Kouides P,Stein D

Funder

National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15713

Reference37 articles.

1. A prospective evaluation of the prevalence of symptomatic von Willebrand disease (VWD) in a pediatric primary care population;Bowman;Pediatr Blood Cancer,2010

2. Epidemiological investigation of the prevalence of von Willebrand's disease;Rodeghiero;Blood,1987

3. Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology;Eikenboom;Best Pract Res Clin Haematol,2001